Augmentation drug study

[involuntarydancer]

I see in the latest Nightwalker that a study is being undertaken by William Ondo MD at Houston Methodist Neurological Institute (Texas) evaluating the possibile role of the drug ecopipam in reversing dopamine agonist augmentation.

They are looking for participants who are:

Available for 6 or 7 visits to the hospital in Houston over a 14 week period (each visit about 90-120 minutes duration);

Now requiring a higher dose of mirapexin, ropinerole or neupro than was originally prescribed - concurrent use of anticonvulsant is allowed but Rls must still be problematic and must start earlier in the day than previously. Those on Opioid, bupropion or Prozac treatments are not eligible.

Contact detail: [e-mail]